Aytu BioScience (AYTU)

1.06 +0.06 (6.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/8/18 *Est.)

Latest Headlines

Form 8-K AYTU BIOSCIENCE, INC For: Nov 05 November 12, 2019 6:07 AM - SEC Filing Aytu BioScience Announces Hiring of Matthew Phillips as Executive Vice President of Commercial Operations November 11, 2019 6:07 AM - StreetInsider Form 8-K/A AYTU BIOSCIENCE, INC For: Nov 01 November 7, 2019 4:58 PM - SEC Filing Form SC 13D/A AYTU BIOSCIENCE, INC Filed by: ARMISTICE CAPITAL, LLC November 7, 2019 4:20 PM - SEC Filing Aytu BioScience to Report Fiscal Q1 FY 2020 Results and Business Update November 7, 2019 8:06 AM - StreetInsider Form 8-K/A AYTU BIOSCIENCE, INC For: Oct 31 November 4, 2019 5:17 PM - SEC Filing Form 8-K AYTU BIOSCIENCE, INC For: Oct 31 November 4, 2019 9:06 AM - SEC Filing Aytu BioScience Announces Closing of $12.4M Prescription Product Portfolio Purchase November 4, 2019 9:01 AM - StreetInsider Form PRE 14A AYTU BIOSCIENCE, INC For: Dec 13 November 4, 2019 8:31 AM - SEC Filing Form 4 AYTU BIOSCIENCE, INC For: Oct 30 Filed by: Armistice Capital Master Fund Ltd. November 1, 2019 5:16 PM - SEC Filing Form D AYTU BIOSCIENCE, INC October 31, 2019 5:25 PM - SEC Filing Form SC 13G AYTU BIOSCIENCE, INC Filed by: Altium Capital Management LP October 21, 2019 5:02 PM - SEC Filing Aytu BioScience Announces Addition of Tuzistra(R) XR to Leading National Pharmacy Benefit Manager's Formulary October 21, 2019 7:02 AM - StreetInsider Aytu BioScience (AYTU) Reports Positive Clinical Results from Natesto Spermatogenesis Study October 17, 2019 8:38 AM - StreetInsider Aytu BioScience Announces Positive Clinical Results from Natesto(R) Spermatogenesis Study October 17, 2019 8:31 AM - StreetInsider Form 4 AYTU BIOSCIENCE, INC For: Oct 11 Filed by: Armistice Capital Master Fund Ltd. October 16, 2019 4:22 PM - SEC Filing Form SC 13D/A AYTU BIOSCIENCE, INC Filed by: ARMISTICE CAPITAL, LLC October 16, 2019 4:17 PM - SEC Filing Aytu BioScience to Announce Results from Natesto(R) Spermatogenesis Study on Thursday, October 17 October 16, 2019 8:31 AM - StreetInsider Aytu Biosciences (AYTU) PT Lowered to $5 at Northland Capital Markets October 15, 2019 7:43 AM - StreetInsider Form 8-K AYTU BIOSCIENCE, INC For: Oct 10 October 15, 2019 7:34 AM - SEC Filing Form 8-K AYTU BIOSCIENCE, INC For: Oct 11 October 15, 2019 7:34 AM - SEC Filing Form 425 AYTU BIOSCIENCE, INC Filed by: AYTU BIOSCIENCE, INC October 15, 2019 7:31 AM - SEC Filing Form 425 AYTU BIOSCIENCE, INC Filed by: AYTU BIOSCIENCE, INC October 15, 2019 7:27 AM - SEC Filing Aytu BioScience (AYTU) Confirms Agreement to Acquire $12.4 Million Prescription Product Portfolio from Cerecor (CERC) October 14, 2019 6:39 AM - StreetInsider Aytu BioScience Acquires $12.4 Million Prescription Product Portfolio October 14, 2019 6:31 AM - StreetInsider Aytu BioScience Announces $10 Million Private Placement October 14, 2019 6:16 AM - StreetInsider Aytu BioScience and Validus Pharmaceuticals Announce ZolpiMist Co-Promotion Agreement and Launch Into the $163 Million Psychiatry Market October 2, 2019 8:06 AM - StreetInsider Form 425 AYTU BIOSCIENCE, INC Filed by: AYTU BIOSCIENCE, INC September 26, 2019 5:13 PM - SEC Filing Form 10-K AYTU BIOSCIENCE, INC For: Jun 30 September 26, 2019 4:48 PM - SEC Filing Aytu BioScience Reports 100% Revenue Growth to $7.3 million in FY 2019 September 26, 2019 4:03 PM - StreetInsider Form 8-K AYTU BIOSCIENCE, INC For: Sep 26 September 26, 2019 4:01 PM - SEC Filing Aytu BioScience Announces Addition of Natesto(R) to Leading National Pharmacy Benefit Manager’s Formulary; Natesto Added to Commercial Plans Covering Over 30 Million U.S. Lives September 24, 2019 8:06 AM - StreetInsider Aytu BioScience to Report Fiscal FY 2019 Results and Business Update September 19, 2019 8:06 AM - StreetInsider Form 8-K AYTU BIOSCIENCE, INC For: Sep 12 September 18, 2019 5:10 PM - SEC Filing Form SC 13D/A AYTU BIOSCIENCE, INC Filed by: ARMISTICE CAPITAL, LLC September 18, 2019 4:54 PM - SEC Filing Aytu Biosciences (AYTU) PT Raised to $4.75 at Ladenburg Thalmann September 18, 2019 12:27 PM - StreetInsider Aytu BioScience to Present at Ladenburg Thalmann 2019 Healthcare Conference September 17, 2019 8:06 AM - StreetInsider Form 425 AYTU BIOSCIENCE, INC Filed by: AYTU BIOSCIENCE, INC September 12, 2019 3:58 PM - SEC Filing Aytu BioScience Announces Definitive Agreement to Acquire Innovus Pharmaceuticals September 12, 2019 8:07 AM - StreetInsider Innovus Pharma (INNV) to Acquire Innovus Pharmaceuticals September 12, 2019 8:05 AM - StreetInsider Aytu BioScience Announces Definitive Agreement to Acquire Innovus Pharmaceuticals September 12, 2019 8:05 AM - BizWire Form 425 AYTU BIOSCIENCE, INC Filed by: AYTU BIOSCIENCE, INC September 12, 2019 7:22 AM - SEC Filing Aytu BioScience Announces Availability of the MiOXSYS(R) Male Infertility Test in South Africa September 10, 2019 8:06 AM - StreetInsider Form SC 13G/A AYTU BIOSCIENCE, INC Filed by: UBS Group AG September 10, 2019 6:07 AM - SEC Filing Aytu BioScience Announces Tuzistra XR Co-Promotion Agreement with Poly Pharmaceuticals September 4, 2019 8:06 AM - StreetInsider Full Article List